Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Plus de 40 000 produits accessibles à 0€ de frais de courtage
Découvrir Boursomarkets
Fermer

NATUREX : Filing of the 2013 Registration document
information fournie par Actusnews 05/05/2014 à 13:30

Avignon, May 5th 2014 - Naturex, world leader in speciality plant-based ingredients, has published its registration document for the year ended December 31st, 2013.

2013 Registration document

The 2013 Registration document was filed with the French Financial Markets Authority (Autorité des Marchés Financiers) on April 30th, 2014 under the number D.14-0456.

This document includes :

  • the annual financial report for the year ended December 31st, 2013 according to article L 451-1-2 of Code monétaire et financier ;
  • the Chairman of the Board of Directors' Report on Corporate Governance, internal control and risk management ;
  • the report relating to the social, environmental and societal informations ;
  • the information related to the Statutory Auditors'fees.

Copies of this document in French language are available free of charge, pursuant to applicable law, and can be downloaded from the company's web site www.naturex.fr, under the « Investors » section, as well as on www.amf-france.org.

English translation of this document will be soon available.

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com

Financial schedule

- Q1 2014 results:
- 2014 H1 sales
- 2014 first-half results
- 2014 third-quarter sales
- 2014 third-quarter results
- Annual revenue
- Annual results
26 May 2014
25 July 2014
29 August 2014
4 November 2014
28 November 2014
3 February 2015
31 March 2015

4 Upcoming events

- AGM 26 June 2014

Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B

Total number of shares comprising the share capital: 7,852,055
ISIN FR0000054694
NATUREX is a component of the CAC PEA-PME, CAC Small, Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

About Naturex

Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 1,450 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.

Contacts

Thierry Lambert
Chairman and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89
t.lambert@naturex.com



Thierry-Bertrand Lambert
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
t.b.lambert@naturex.com
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Information réglementée
Communiqués de mise à disposition de documents :
- Modalités de mise à disposition de document de référence ou de ses actualisations Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-35825-2013-05-05-Registration-document-filing-2013.pdf

Valeurs associées

Euronext Paris 0.00%

0 commentaire

Signaler le commentaire

Fermer

Mes listes

Cette liste ne contient aucune valeur.